Chemical Structure and Generations
The molecular backbone consists of an aminocyclitol ring linked via glycosidic bonds to amino sugars. Natural compounds are produced by soil actinomycetes of the genera Actinomyces and Micromonospora.
Pharmacologically, they are divided into three generations:
- First generation: Streptomycin, neomycin, kanamycin.
- Second generation: Gentamicin, tobramycin, netilmicin.
- Third generation: Amikacin (exhibits the broadest spectrum and is resistant to many bacterial inactivating enzymes).
Mechanism of Transport and Action
Cellular uptake occurs in two steps: passive diffusion through porins followed by an energy-dependent active transport across the cytoplasmic membrane. This process critically requires oxygen, rendering these drugs ineffective against anaerobes.
Inside the cell, aminoglycosides exert a bactericidal effect:
- Bind to the 30S ribosomal subunit.
- Induce mRNA misreading, leading to incorrect codon-anticodon recognition.
- Stimulate the production of defective (aberrant) proteins.
- Aberrant proteins incorporate into the cell membrane, disrupting its integrity and facilitating the entry of additional antibiotic molecules.
Pharmacokinetics and Synergy
Being polycations, aminoglycosides are highly hydrophilic (lipophobic), poorly absorbed from the GI tract, and not metabolized in the body, being cleared exclusively by the kidneys.
A key clinical feature is their synergism with beta-lactams: penicillins disrupt the cell wall, enhancing the intracellular penetration of aminoglycosides. For example, the combination of gentamicin with ampicillin or penicillin is synergistic for treating severe Enterococcus endocarditis.
Side Effects and Limitations
Systemic administration requires careful therapeutic drug monitoring due to severe adverse effects:
- Pronounced ototoxicity (auditory and vestibular damage).
- Nephrotoxicity (acute tubular necrosis).
- Risk of neuromuscular blockade, which can precipitate respiratory depression.
- Contraindications include pregnancy, myasthenia gravis, pre-existing renal impairment, and cranial nerve VIII pathology.